SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-047338
Filing Date
2022-04-19
Accepted
2022-04-19 16:13:15
Documents
4
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2212715-1_def14a.htm DEF 14A 628105
2 GRAPHIC lg_entradatherapeutic-4clr.jpg GRAPHIC 86857
3 GRAPHIC tm2212715d1-px_entrapg1bw.jpg GRAPHIC 441237
4 GRAPHIC tm2212715d1-px_entrapg2bw.jpg GRAPHIC 386669
  Complete submission text file 0001104659-22-047338.txt   1888046
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40969 | Film No.: 22835078
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences